---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40251916.md"
description: "$Novo Nordisk AS(NVO.US) The only thing to be wary of is the massive capital expenditure in 2025."
datetime: "2026-04-28T08:35:38.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40251916.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40251916.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40251916.md)
author: "[奥马哈的信徒皮球](https://longbridge.com/en/profiles/18328374.md)"
---

# $Novo Nordisk AS(NVO.US) The only thing to be wary…


### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Comments (3)

- **满仓等暴涨 · 2026-04-28T13:01:04.000Z · 👍 1**: This is exactly what's happening with semiconductors now, it's just that no one is paying attention to weight-loss drugs, waiting
- **Louis Tang · 2026-04-28T09:24:10.000Z · 👍 1**: Currently, only about 1% of obese patients worldwide are using weight-loss drugs for treatment. It is correct for pharmaceutical companies to invest a large amount of capital expenditure to expand production capacity.
  - **奥马哈的信徒皮球** (2026-04-28T10:06:00.000Z): Haha, I didn't say anything wrong.